AAAAAA
Results:
1-12
|
Results: 12
Authors:
Moore, KW
Stepien, RL
Citation: Kw. Moore et Rl. Stepien, Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patent ductus arteriosus in 4 dogs, J VET INT M, 15(4), 2001, pp. 418-421
Authors:
Moore, KW
Malefyt, RD
Coffman, RL
O'Garra, A
Citation: Kw. Moore et al., Interleukin-10 and the interleukin-10 receptor, ANN R IMMUN, 19, 2001, pp. 683-765
Authors:
Crepaldi, L
Gasperini, S
Lapinet, JA
Calzetti, F
Pinardi, C
Liu, Y
Zurawski, S
de Waal Malefyt, R
Moore, KW
Cassatella, MA
Citation: L. Crepaldi et al., Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10, J IMMUNOL, 167(4), 2001, pp. 2312-2322
Authors:
Ding, YZ
Qin, LH
Zamarin, D
Kotenko, SV
Pestka, S
Moore, KW
Bromberg, JS
Citation: Yz. Ding et al., Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation, J IMMUNOL, 167(12), 2001, pp. 6884-6892
Authors:
McKernan, RM
Rosahl, TW
Reynolds, DS
Sur, C
Wafford, KA
Atack, JR
Farrar, S
Myers, J
Cook, G
Ferris, P
Garrett, L
Bristow, L
Marshall, G
Macaulay, A
Brown, N
Howell, O
Moore, KW
Carling, RW
Street, LJ
Castro, JL
Ragan, CI
Dawson, GR
Whiting, PJ
Citation: Rm. Mckernan et al., Sedative but not anxiolytic properties of benzodiazepines ave mediated by the GABA(A) receptor alpha(1) subtype, NAT NEUROSC, 3(6), 2000, pp. 587-592
Authors:
Oppmann, B
Lesley, R
Blom, B
Timans, JC
Xu, YM
Hunte, B
Vega, F
Yu, N
Wang, J
Singh, K
Zonin, F
Vaisberg, E
Churakova, T
Liu, MR
Gorman, D
Wagner, J
Zurawski, S
Liu, YJ
Abrams, JS
Moore, KW
Rennick, D
de Waal-Malefyt, R
Hannum, C
Bazan, JF
Kastelein, RA
Citation: B. Oppmann et al., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, IMMUNITY, 13(5), 2000, pp. 715-725
Authors:
Debets, R
Timans, JC
Churakowa, T
Zurawski, S
Malefyt, RD
Moore, KW
Abrams, JS
O'Garra, A
Bazan, JF
Kastelein, RA
Citation: R. Debets et al., IL-18 receptors, their role in ligand binding and function: Anti-IL-1RAcPLantibody, a potent antagonist of IL-18, J IMMUNOL, 165(9), 2000, pp. 4950-4956
Authors:
O'Farrell, AM
Parry, DA
Zindy, F
Roussel, MF
Lees, E
Moore, KW
Mui, ALF
Citation: Am. O'Farrell et al., Stat3-dependent induction of p19(INK4D) by IL-10 contributes to inhibitionof macrophage proliferation, J IMMUNOL, 164(9), 2000, pp. 4607-4615
Authors:
Moore, KW
Trepanier, LA
Lautzenhiser, SJ
Fialkowski, JP
Rosin, E
Citation: Kw. Moore et al., Pharmacokinetics of ceftazidime in dogs following subcutaneous administration and continuous infusion and the association with in vitro susceptibility of Pseudomonas aeruginosa, AM J VET RE, 61(10), 2000, pp. 1204-1208
Authors:
Moore, KW
Bonner, K
Jones, EA
Emms, F
Leeson, PD
Marwood, R
Patel, S
Patel, S
Rowley, M
Thomas, S
Carling, RW
Citation: Kw. Moore et al., 4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D-4 receptors, BIOORG MED, 9(9), 1999, pp. 1285-1290
Authors:
Coombe, VT
Moore, KW
Hutchings, MJ
Citation: Vt. Coombe et al., TIE and TRE: An abbreviated guide to dealing with toxicity, WATER SCI T, 39(10-11), 1999, pp. 91-97
Authors:
Carling, RW
Moore, KW
Moyes, CR
Jones, EA
Bonner, K
Emms, F
Marwood, R
Patel, S
Patel, S
Fletcher, AE
Beer, M
Sohal, B
Pike, A
Leeson, PD
Citation: Rw. Carling et al., 1-(3-cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A selective high-affinity antagonist for the human dopamine D-4 receptorwith excellent selectivity over ion channels, J MED CHEM, 42(14), 1999, pp. 2706-2715
Risultati:
1-12
|